Background: Rotator cuff tears are the most common tendon injury in the adult population, resulting in substantial morbidity. The optimum management for these patients is not known.
in patient-reported outcomes over time, with no clear superiority of one treatment modality over the other. 21, 40, 42, 76 For other chronic painful conditions, randomized trials have indicated that outcomes improve over time among patients regardless of their treatment. 3, 4, 88 This may be due to the natural history of chronic musculoskeletal conditions, regression to the mean, or other unrecognized mechanisms. As a result, it presents a challenge for the interpretation of outcomes from studies of patients with rotator cuff tears. Randomized trials are a good source of information on the natural history of a condition because they have well-defined entry criteria, are prospective by definition, and typically have well-defined follow-up time points. In addition, the natural history of patients with rotator cuff pathologic conditions in RCTs needs to be better understood to improve the planning and conduct of further trials in this area.
The aims of this article are to assess the outcomes and trajectories over time among patients with full-thickness rotator cuff tears in randomized clinical trials.
METHODS
This study was reported in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. The systematic review protocol was predefined and can be found at http://www.crd.york.ac .uk/PROSPERO (CRD42016047715).
Inclusion Criteria
Inclusion criteria were as follows: (1) full-text RCTs in English language, (2) any humans of any age with isolated full-thickness rotator cuff tears, (3) studies comparing both operative and nonoperative interventions, and (4) reporting clinical outcome measures chosen for this review.
Exclusion Criteria
Exclusion criteria included (1) nonrandomized studies, (2) studies reporting biomechanical and radiologic outcomes, (3) studies not reporting clinical outcomes selected for this review, and (4) abstract publication only. Studies examining patients with partial-thickness tears or treatments for shoulder disorders other than full-thickness tears were also excluded.
Up to 3 attempts were made to contact the corresponding author for additional information if (1) further information was required about study design to confirm inclusion, (2) there were missing data for unreported or partially unreported outcomes, or (3) outcomes were for the fullthickness subpopulation where the study population was mixed (full thickness and other pathologic conditions).
Outcome Measures
The primary outcome measure was the Constant shoulder score 22 at 52 weeks. The Constant score is the most widely used shoulder evaluation score in Europe 52 and has been described as the most efficient outcome measure for patients with rotator cuff tears. 62 It is a composite score measuring a combination of physical examination and subjective assessments from the patient.
The secondary outcome measures included scores for the following, at all time points: (1) the American Shoulder and Elbow Surgeons (ASES) score 82 ; (2) the University of California, Los Angeles (UCLA) score 2 ; (3) the Disabilities of the Arm, Shoulder and Hand (DASH) score 41 ; and (4) the Constant (including modifications). 22 
Search Strategy and Quality Assessment
We searched Medline, Embase, the Cochrane Central Register of Controlled Trials, and CINAHL from inception to September 14, 2016, and imported citations into EndNote X7 reference management software. For a full search strategy, see the Appendix (available in the online version of this article). After removal of duplicates, citations were screened with title and abstract per the applied inclusion criteria. To reduce the risk of publication bias, if multiple studies reported the same or an overlapping population, only the study with the longest follow-up was included. For those studies that potentially met eligibility criteria, full texts were obtained. Two authors (C.K. and I.A.) independently assessed each paper, with any discrepancies being resolved through discussion with the senior authors (N.A.S. and A.J.M.).
We did a qualitative risk-of-bias assessment with the Cochrane guidelines. 38 Where the main paper did not include sufficient information to complete risk-of-bias assessment, any published protocols were also examined.
Statistical Analysis
We extracted outcome data from each study according to follow-up period. As there was often wide heterogeneity in follow-up, the exact time point was recorded, even if different for study arms. As performed in a similar metaanalysis by Artus et al, 4 we developed a data analysis plan, including a descriptive analysis, an assessment of the variation of size of response, and, finally, the overall pattern of response before data extraction.
Extracting Data
We extracted the number of patients in each arm and the intervention type for each arm, defined as repair, acromioplasty alone, or nonoperative. In addition, the mean 6 SD of the Constant score (standard and modified), sex, dominant hand, and time point assessed were extracted for each study. If a study did not report 1 of these statistics, then estimates of missing values were calculated from other reported values, such as the test statistic or P value, with standard methods as described in the Cochrane handbook. 39 Where data in studies were not represented in numeric format, 2 authors (C.K. and I.A.) extracted data from graphs to improve accuracy.
Assessing the General Response of Treatment
Outcome scores were graphically plotted against time with Microsoft Excel to describe change from baseline to all follow-up points reported in all treatment arms from included studies. Data were explored visually for a descriptive analysis of response. As a visual response trend was required, studies with modified versions of Constant score were included.
Assessing Variation of Size of Response
To determine variation in size of response, we analyzed the change in outcome score by calculating the bias-corrected standardized mean change (SMC) at 3, 6, 12, and 24 months. This technique is frequently used when studies report efficacy in terms of a continuous measurement. For example, it could be used to evaluate a new analgesic drug by comparing, as an outcome, visual analog scale scores for pain between intervention and placebo. The SMC could be interpreted as the ''standardized'' measure of outcome: if there were no difference between the interventions, the SMC would be zero, whereas a negative SMC value would represent a reduction in pain (ie, if high scores denoted more severe pain). The SMC score is calculated by subtracting the follow-up mean score in the chosen outcome measure from the baseline mean score. This is then divided by its pooled SD and multiplied by a bias correction factor based on the group size. 71 If the pooled SD was not reported, either baseline SD was used or the SD at follow-up. Estimates of the variance of the SMC were also calculated 71 and used to construct 95% CIs. To allow for the repeated measures design, the within-group correlation was set at 0.5 for all studies. 18 
Summarizing the Overall Response to Treatment
As the SMC standardizes the measurement of change over time, studies with slightly different scales can be pooled for comparison. As such, studies with modified or adjusted Constant scores were combined alongside those that reported unmodified scales. In a similar meta-analysis, 4 1 arm was then randomly selected per trial because changes in outcome over time were of interest rather than between-arm comparison (eg, to demonstrate superiority of 1 type of intervention). Intervention arms from each study are likely to be further correlated since participants recruited to each trial are likely to have similar characteristics and therefore a similar response to treatment, which means that observations from different study arms would not be independent. Furthermore, the objective of this review is to describe the effect of treatments and not to estimate effect sizes among intervention groups.
We calculated a combined pooled estimate of SMC for each time point with a random effects model. Studies were subcategorized according to treatment given: primary repair, acromioplasty only, or nonoperative treatment. If patients had a primary repair and another treatment adjunct was applied (eg, the application of platelet-rich protein or acromioplasty), the study arm was allocated to the repair group. We did a simple correlation analysis (with Pearson correlation coefficient) on the SMCs between all pairs of time points to assess the relationship of each interval.
Analyses were conducted in R (https://www.r-project .org/) and with the metafor package.
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RESULTS
A total of 1033 citations were received from our search strategy. After removal of duplicates and screening of studies by title and abstract, 100 full-text papers were retrieved. Of these, 57 studies met our inclusion criteria, from which 43 studies used the Constant score as an outcome measure (Figure 1) . Of the 57 studies selected, 14 study authors were contacted for further information; however, no responses were received.
Description of Studies Included
With respect to studies reporting the Constant score, 39 studies with 73 arms described treatment response for operative interventions, of which 8 studies with 8 arms had repair and acromioplasty performed; 2 studies with 2 arms, acromioplasty only; and 5 studies with 7 arms, nonoperative interventions. Twenty-six studies with 53 arms reported the ASES score; 20 with 40 treatment arms reported the UCLA score. The DASH was the least frequently reported score, with 7 studies reporting 14 treatment arms. A description of the included studies is available in Appendix Table A1 . §
Description of Patient Population Included
We included data from 4542 participants in this review, with study populations ranging from a minimum of 20 to 248 patients. Within the included studies, 8 did not report sex. Of those that did report sex, 48% of participants were male. Four studies out of 57 did not report age; in those that did, the median of the mean reported age of participants was 59.0 years (interquartile range, 5.3 years). Of the studies included, 27 did not report the dominant hand of included patients. From those studies reporting, 71% of participants had a full-thickness tear of the dominant side.
Risk-of-Bias Assessment
Studies included in this review had a low risk of bias for all domains apart from blinding of participants and personnel (performance bias); 42% (24 of 57 studies) had a low risk of performance bias: 47% (27 of 57 studies) had an unclear risk of bias (Figure 2 ).
General Response to Treatment
There was an overall improvement in all arms from baseline for studies reporting the Constant score (Figure 3 ). When differences between operative and nonoperative arms were explored, this effect was sustained, with all study arms showing positive change. Treatment response in all outcome measures (ASES, UCLA, and DASH) showed an improvement in functional outcomes regardless of treatment intervention applied (Figure 4 ). Studies that followed up patients at multiple time points indicated an improvement in outcome in the first 12 months, after which the rate of improvement stabilized. This pattern was consistent irrespective of treatment type given (primary repair, acromioplasty only, or nonoperative intervention).
Summary of Responses to Treatment
A forest plot describing the pooled SMC from baseline for all sampled treatment arms was produced for the Constant score ( Figure 5 ). This showed a large pooled treatment response at 3 months (1.42; 95% CI, 0.80-2.04) and at 6 months (2.73; 95% CI, 1.06-4.40). The largest change was seen at 12 months (3.18; 95% CI, 1.64-4.71), which then reduced slightly at 24 months (2.98; 95% CI, 1.40-4.55).
In the subgroup analysis, the greatest effects were seen among patients undergoing rotator cuff repair, although a meta-analysis of papers directly comparing repair, acromioplasty, and nonoperative treatment was not performed; therefore, this should not be taken as direct evidence of benefit for repair. Trends in the effects followed the same pattern as observed in the main analysis, with the largest effects observed at 12 months (SMC, 3.65; 95% CI, 1.74-5.56) for patients undergoing repair, as opposed to those being treated nonoperatively (SMC, 1.78; 95% CI, 1.10-2.46) and with acromioplasty (SMC, 0.27; 95% CI, 0.01-0.53).
There was a strong correlation in SMCs between time points, which increased as the studies progressed. Pearson correlation coefficients were as follows: 0.816 (n = 11; 95% CI, 0.424-0.951) between 3 and 6 months, 0.987 (n = 13; 95% CI, 0.957-0.996) between 6 and 12 months, and 0.999 (n = 9; 95% CI, 0.996-1.00) between 12 and 24 months.
DISCUSSION
We aimed to collate the evidence on the short-term natural history of patients with symptomatic full-thickness rotator cuff tears, regardless of the treatment they received. The studies included in this review examined a variety of treatment modalities, including various operative techniques as well as nonoperative interventions. In this review, we found that treatment response follows a similar pattern of rapid improvement in the first 12 months after an intervention, after which the recovery plateaus. This pattern was revealed in all treatment arms irrespective of intervention applied, including surgical or nonsurgical care.
While assessing the natural history of a condition with randomized trial data alone may seem counterintuitive, there are a number of good reasons for doing so. Randomized trials typically have well-organized follow-up arrangements at fixed periods from randomization, which are usually predefined. By definition, they are prospective studies of welldefined populations. A well-constructed cohort study can also achieve this objective; however, it is harder to detect and assess in review, and many cohort studies suffer from being conducted with cross-sectional sampling-meaning that follow-up times vary considerably from the intervention. This may be valuable in a long-term follow-up study, but the purpose of this study was to examine short-to medium-term outcomes (ie, in the first few months and years after the intervention); as such, randomized trials provide a wealth of prospective data with fixed time points for follow-up.
In determining an explanation for the patterns that we observed, we must give consideration to the natural history of rotator cuff tears. Previously conducted systematic reviews commented on the scarcity of studies investigating the topic. 28 A cohort study by Safran and colleagues 85 assessing the natural history of symptomatic full-thickness rotator cuff tears that were managed nonoperatively revealed that patients often had progression in tear size that was linked to a deterioration into greater pain. This is different from our findings, where we found that outcome measures improved among patients treated nonoperatively. Safran et al did not explain why their cohort was treated nonoperatively; perhaps, operative intervention was unsuitable for these patients. On comparison, in half the studies included in this review with a nonoperative arm, operative intervention would have been suitable for the participants. In addition, people included in studies with only nonoperative arms may not have had significant disability to seek operative intervention. As such, this may represent 2 different subsections of the population.
Moosmayer et al 70 found that patients with asymptomatic rotator cuff tears often progressed to become symptomatic, representing a structural deterioration of the rotator cuff. However, this patient cohort differs from those entered into RCTs, as asymptomatic patients are unlikely to actively seek health care. In contrast, patients seeking surgical treatment are likely to represent a subsection of the population with the worst symptoms, leading to lower baseline outcome scores. As such, these patients also represent those who have the potential for larger reductions in symptoms and, therefore, the greatest treatment response.
The phenomenon of regression to the mean is a ubiquitous statistical occurrence in repeated data. This suggests that if a variable is extreme on its first measurement, it will tend to be closer to the population mean on subsequent measurements. 72 For example, say that a patient's pain varies: she or he will typically see a specialist and enter treatment (or a study) when the pain is at its peak; however, in future measurements, the pain will be reduced as it falls from the peak. As such, patients with worse baseline outcome measures represent those with greater potential to improve. Equally, it may be that patients who have pain and symptoms will recover with time and care, as implied by those studies where there is a large effect and regression to the mean may seem unlikely. In reality, it is difficult to separate the effects of regression to the mean from the true natural history of full-thickness tears.
Thought must also be given to nonspecific factors for change in outcomes. Indeed, there is evidence to suggest that participation in RCTs may itself confer benefit to patients.
14 This effect is particularly seen in situations where effective treatments are included in the trial protocol, 14 such as that for many studies included in this review. Other factors-including trust in the health care professional delivering the treatment 11 and the manner in which patients' expectations for treatment response are enhanced by positive information 12 -all significantly contribute to the improvement of health outcomes. In addition, attributes of the patients (eg, their expectations, emotions, and psychological conditioning) were found to be of positive influence. 53, 78 Perhaps the best recognized is the role of the placebo in influencing outcomes. There is evidence that placebo, or nonspecific effects, related to the clinical encounter can be an effective treatment for musculoskeletal disorders. 95 Furthermore, the placebo can be augmented with previously mentioned factors, such as clinician warmth. 46 Again, it is difficult to estimate the effect of these factors onto the trials included in this study.
One other consideration is the timing of outcomes in randomized studies. It is common for reviewers to insist on 24-month outcomes; however, we found that they add little value beyond 12 months. After 12 months in all treatment arms, the improvement stabilized, and correlations in scores at different time points were very high. In other words, once the 12-month outcomes were known, the 24-month outcomes were highly predictable. We recommend a 12-month primary outcome on the basis of our findings. This has important implications in the delivery of randomized trials, which are often expensive and time-consuming. Reporting at 12 rather than 24 months would save substantial cost as well as time in producing an answer that can be delivered to improve clinical care for patients, whereas waiting for a 24-month follow-up adds little. This is not to say that later follow-up (say, 5 or 10 years) does not add different or valuable information, but in terms of short-to medium-term outcomes, a primary outcome at 12 months can be recommended on the basis of our findings.
Surgical treatments may be effective, although their true benefit over nonoperative treatment is likely to be much less than the effect seen in uncontrolled case series. Our data show that such an improvement may also be seen with nonoperative treatments. The overall effect of surgery can be assessed only by comparing it with nonoperative treatment, and consideration should be given to sham-or placebo-controlled trials of surgery. 33, 92 When assessing the results of surgical procedures versus other treatments or procedures, surgeons should be aware of the natural history of symptomatic cuff tears in the short term to improve substantially with nonoperative care alone.
Strengths and Limitations
This study was conducted and reported in accordance with the PRISMA guidelines. 67 It was conducted with a predefined and published study protocol.
We used the Constant score as the primary outcome measure. It is the most widely used assessment tool 52 and was the most frequently reported outcome measure in studies included in this review, thus providing the greatest volume of data to pool. The other measures used in this review-namely, the ASES, UCLA, and DASH scores-were the next commonly reported and thus represented appropriate secondary outcomes. A small number of trials used other measures, such as change in visual analog scale score or radiologic outcomes, which were therefore not included. As these were so infrequently reported and varied in their definitions, any meaningful pooling of these data would not have been possible.
Only trials with fully published outcome measures were included. Thus, there is a risk of publication bias from studies with incomplete outcome data, which were excluded from the study analysis. In accordance with the Cochrane guidelines, authors were contacted with reasonable effort to minimize this risk. A further limitation is that only English-language studies were included. However, this resulted in only 2 studies being excluded, and those that were included were from a wide geographic distribution. The large number of included studies showing consistent results suggests that our conclusions would not have changed had any other such studies been included.
This study was not designed as a meta-analysis to directly compare rotator cuff repair, acromioplasty, or physiotherapy; rather, it is a description of the natural history of each treatment. Conclusions on the relative merits of the treatments should not be directly inferred from these findings. Different studies are included, which may have had different populations in them. An example of this is the apparent worse performance of acromioplasty relative to repair or nonoperative care. While the current study did adjust for baseline scores, the different studies included were not necessarily based on the same population of patients or type of tear, so care should be taken not to overinterpret our findings. However, it makes an important statement about the likely outcome of patients with symptomatic cuff tears over time, and this needs to be considered when interventions such as surgery are being considered or when other treatments are being evaluated.
We did not assess the long-term outcomes of these patients. Certainly, it is established that massive rotator cuff tears can lead to the development of rotator cuff arthropathy. 26 This may then result in a deterioration of outcomes, and there is evidence to suggest that early repair of rotator cuff tears can prevent progression into rotator cuff arthropathy. 20, 73 Unfortunately, long-term outcomes were beyond the scope of this review, as it was based on trial data, which typically do not extend long enough to assess long-term outcomes.
CONCLUSION
We show that patients with symptomatic full-thickness rotator cuff tears demonstrate a consistent and considerable response to treatment, even with nonoperative management. The largest improvement occurs in the first 12 months, after which the response stabilizes. When the treatment effect of invasive surgery is assessed, consideration must be given to the natural history of patients with rotator cuff tears to improve over time with nonoperative care as well.
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